ETOPOSIDE - CHEMISTRY, PRE-CLINICAL AND CLINICAL-PHARMACOLOGY

被引：48

作者：

ACHTERRATH, W

NIEDERLE, N

RAETTIG, R

HILGARD, P

机构：

[1] UNIV ESSEN GESAMTHSCH, HOSP & POLYCLIN TUMOR RES, W GERMAN TUMOR CTR, D-4300 ESSEN 1, FED REP GER

[2] BRISTOL MYERS INT, B-1170 BRUSSELS, BELGIUM

来源：

关键词：

D O I：

10.1016/S0305-7372(82)80072-8

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：3 / 13

页数：11

共 65 条

[11]

BURCHENAL JH, 1980, CISPLATIN CURRENT ST

[12]

CHIUTEN DF, 1979, P AM ASSOC CANC RES, V20, P402

[13]

CORBETT TH, 1978, CANCER TREAT REP, V62, P1471

[14]

CREASY WA, 1975, ANTINEOPLASTIC IMMUN, V2

[15]

CREASY WA, 1979, MECHANISM ACTION ANT

[16]

CREAVEN PJ, 1975, CLIN PHARMACOL THER, V18, P221

[17]

DINCALCI M, 1981, P AM ASSOC CANC RES, V22, P357

[18]

DINCALCI M, 1981, COMMUNICATION

[19]

DINCALCI M, 1981, NEW DRUGS CANCER THE

[20]

DOMBERNOWSKY P, 1973, ACTA PATH MICRO IM A, VA 81, P715